The present work aims to evaluate the response of the adult gerbil female prostate (paraurethral glands) and ovaries to shortterm exposure to antiestrogenic agents, consisting of daily oral doses of letrozole (1 mg kg À1 day À1 ) or intradermal doses of tamoxifen (1 mg/kg) every other day for 21 days. The serum levels of testosterone and estradiol were monitored, and the prostates and ovaries collected for structural, ultrastructural, and immunocytochemical analyses. The letrozole treatment resulted in increases of serum testosterone levels and secretory activity as well as in glandular hyperplasia and dysplastic growth, simulating the effects caused by the exogenous androgens. The effects caused by tamoxifen indicate that this endocrine agent acted as an estrogenic agonist on the prostate, causing glandular hypertrophy, secretory activity decrease, and the development of prostatic lesions. Therefore, it is possible to conclude that the letrozole and tamoxifen therapies result in a series of complex effects that endanger the physiology of hormone-dependent organs, including the female prostate and ovaries. The hormonal imbalance caused by administration of these drugs resulted in considerable changes in prostatic morphology, in a manner very similar to what occurs during the development of prostatic lesions in aged postmenopausal women. Thus, these therapies must be chosen carefully since long-term treatments can result in female prostate dysplasic lesions.
INTRODUCTION
The female prostate or Skene paraurethral gland is a mature and differentiated gland present in several female mammals, including rodents and women, whose function is to produce a prostatic secretion fluid during the sexual act [1] [2] [3] [4] [5] . Biochemical studies demonstrated that female prostatic fluid released during female ejaculation has the same chemical composition as male prostatic fluid. The more abundant components of the human female ejaculate are PSA, PSAP, zinc, and fructose. Evidence indicates that the fructose produced by this gland flows in a small amount from the urethra to the vagina and plays a role in reproduction. Thus, since fructose is the main source of energy for spermatozoa, female prostatic fluid also contributes to the success of fertilization [1, 2] .
The gerbil (Meriones unguiculatus, Criscetidae, Gerbilinae) female prostate [3, 4] presents homology with the ventral prostate in male rodents [5, 6] and with the human female prostate [7] . While the male prostate surrounds the urethra, the female prostate lies in the wall of the female urethra [2, 4] . This is the basic macroscopic difference between the male and female prostate glands. Despite the smaller space available for the female prostate surrounding the female urethra, it possesses all the structural components characteristic of the male prostate, such as functional epithelium and developed surrounding stroma [2] . Although there are many works that describe the histological structure of this gland, little is known so far about the factors that regulate its function.
Testosterone treatment of adult gerbil female prostate [8, 9] showed that this organ's epithelial and stromal cells express androgen receptors and that the hormonal stimulus causes secretory activity increase and dysplastic growth. Therefore, as it is a steroid-regulated gland, the changes in the hormonal serum levels can alter the female prostate structure and physiology.
Nowadays, accounts of the development of prostatic lesions in aging women have been increasing [10] . In addition to the biological and behavioral implications mentioned previously, the main focus of interest about the female prostate comes from its capacity of developing several lesions during aging [11] . Recent works have described the occurrence of cancers of the urethra, whose origin is the female prostate [10, [12] [13] [14] [15] [16] [17] [18] . Furthermore, there is evidence that other prostatic lesions, such as prostatitis and benign prostatic hyperplasia, can occur in the female prostate with the same level of severity observed in the male prostate [2] . The appearance of these lesions is associated with the hormonal imbalance that occurs in older women because of the ovary's postmenopausal failure to produce steroids [2] .
Because of the increasing incidence of breast cancers positive for estrogen receptor, several antiestrogenic therapies have been developed in order to prevent tumoral progression [19, 20] . The most indicated therapeutic agents are letrozole [21] [22] [23] and tamoxifen [24] or a combination of both [20, 25, 26] . These drugs have also been suggested as useful substances for suppressing male prostate cancer, whose cells become highly proliferative because of the combined action of androgens and estrogens [27] .
Letrozole is a nonsteroidal inhibitor of the enzyme aromatase that can prevent up to 99% of peripheral conversion of testosterone into estrogen [22] . Tamoxifen is a nonsteroidal triphenylethylene that acts antagonistically on estrogen by binding competitively to the estrogen receptor [24] . Both drugs cause drastic hormonal changes that can influence the physiology of all the reproductive organs regulated by hormones. Given that the gerbil female prostate is responsive to changes in steroid hormones levels, it is relevant to observe the effect of these endocrine agents on the maintenance of glandular homeostasis.
Therefore, the present study aims to evaluate the response of the adult gerbil female prostate during a short-term exposure to antiestrogenic agents by observing how the hormonal imbalance can alter normal female prostate physiology.
MATERIALS AND METHODS

Animals and Experimental Design
Ninety 3-mo-old female gerbils (M. unguiculatus, Gerbillinae: Muridae) were employed in this study. Ten control animals received corn oil injections every other day for 21 days. Forty animals received oral doses of letrozole (LET; Femara, Novartis-Pharma, Basileia, Switzerland; 1 mg kg À1 day À1 in 0.25 ml corn oil) for 21 days, as described by Tobin and Canny [28] . In the other group, forty animals received intradermic tamoxifen citrate injections (TAM; Sigma Chemical Co., St. Louis, MO; 1 mg/kg every other day in 0.25 ml corn oil) for 21 days, as described by Fitts and colleagues [29] . The treated animals were killed after 3, 7, 14, and 21 days of treatment. After being anesthetized by CO 2 inhalation, the animals were weighed and immediately decapitated. Blood samples from some of them were colleted for serological analysis. The tissues (urethra plus prostatic tissue and ovaries) were dissected out, weighed, and fixed according different protocols, as specified here. The urethra plus adjacent tissues were dissected out using an Olympus SD-ILK stereoscopic microscope (Olympus Optical Co. Ltd., Tokyo, Japan) to remove the adipose tissue and isolate the prostatic tissue plus the associated urethral segment. The separation of these components was performed by sectioning it at the base of bladder to obtain a block containing the entire urethra and prostate tissue (UPT). Animal handling and experiments were performed according to the ethical guidelines of the São Paulo State University, following the Guide for Care and Use of Laboratory Animals (National Institues of Health). The large number of individuals employed in this work was justified by the minute size of the organ and the large number of analytical procedures employed.
Plasma Total Testosterone, Estradiol, and Prostate-Specific Antigen Levels
Circulating serum testosterone, estradiol, and prostate-specific antigen (PSA) levels were determined by immunochemical assays. The PSA levels were indirectly evaluated because it is well known that rats and mice do not express PSA [30] . Previous work using gerbil model described this analysis considering a PSA-like protein or a kallikrein family serinoprotein that show cross-reactivity with the antibodies employed in this work [8] . After the animal's decapitation, blood was collected, and the serum was separated by centrifugation (3000 rpm) and stored at À208C for subsequent hormone assay. Measurements were performed by chemiluminescence immunoassay in an automatic analyzer Vitros-ECi (Johnson & Johnson, Orthoclinical Diagnostics Division, Rochester, NY). The sensitivity was 0.1-150 ng/ml for testosterone, 0.1-3814 pg/ml for estradiol, and 0.1-100 ng/ml for human PSA. The intraassay variations were 1%, 1.1%, and 0.97% and the interassay variations 2.1%, 1.5%, and 1.75% for testosterone, estradiol, and human PSA, respectively.
Structural Analysis
The urethra and adhering tissues and ovaries were fixed by immersion in Karnovsky solution (5% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, or in 4% paraformaldehyde for 24 h). After fixation, the tissues were washed under running tap water, dehydrated in an ethanol series, cleared in xylene, embedded in paraffin (Histosec, Merck, Darmstadt, Germany) or glycol methacrylate resin (Historesin embedding kit, Leica, Nussloch, Germany), and cut into 3-lm sections with a automatic rotatory microtome (Leica RM2155). Sections were stained with hematoxylin-eosin for general morphological analysis (H&E [31] , Weigert's resorcin-fucsin modified for elastic fibers [32] , and Gömöri's reticulin for collagen and reticular fibers in prostatic tissue [33] ). The specimens were analyzed with a Zeiss-Jenaval (Zeiss-Jenaval, Jena, Germany) or Olympus BX60 light microscope (Olympus, Hamburg, Germany), and the images were digitalized using the Image-Pro Plus version 4.5 for Windows software.
Immunocytochemistry
Sections of 4% paraformaldehyde-fixed female prostates were subjected to immunocytochemistry for the detection of androgen receptor (AR) and estrogen alpha receptor (ESR1), as described in protocols applied to the prostate [8, 9, 34] . Primary antibodies to AR (rabbit polyclonal IgG, N-20) and ESR1 (rabbit polyclonal IgG, MC-20) (Santa Cruz Biotechnology, Santa Cruz, CA) were employed at a dilution of 1:100 and 1:50, respectively. Peroxidase-conjugated specific antibodies (Sigma) and 3,3 0 -diaminobenzidina were used as secondary antibodies and peroxidase substrate, respectively. For detection of apoptosis in ovaries, the sections were processed according to the instructions supplied by the manufacturer of the apoptosis kit (TdT-FragEL-DNAfragmentation detection kit; Calbiochem & Oncogene, Darmstadt, Germany), which is based on the TUNEL reaction. Sections were counterstained with Harrys hematoxylin.
Morphometric and Stereological Analysis
The stereological analyses were carried out using Weibels multipurpose graticulate with 130 points and 60 test lines [35] to compare the relative proportion (relative volume) of each prostatic tissue component (epithelium, lumen, muscular stroma, and nonmuscular stroma) as described by Huttunen and collaborators [36] for prostatic tissue. Thirty microscopic fields were chosen at random. In summary, the relative values were determined by counting the coincident points of the test grid and dividing them by the total number of points. Absolute volumes could not be determined because it was not possible to separate the female prostate from adhering tissue and to determine its weight.
The number of secretory, clear, and basal epithelial cells per alveolus was counted, and the individual contribution of each cell type is expressed as a percentage. Morphometric analysis also included the determination of epithelial cell thickness, smooth muscle cell and collagen layer thickness, nucleus/ cytoplasm ratio, nuclear area (lm 2 ), nuclear perimeter (lm), and form factor (4p 3 nuclear area/[nuclear perimeter] 2 ).
Ultrastructural Analysis
The female prostate fragments were fixed by immersion in 3% glutataldehyde plus 0.25% tannic acid solution in Millonings buffer, pH 7.3, containing 0.54% glucose for 24 h. After washing with the same buffer, they were postfixed with 1% osmium tetroxide for 2 h, washed again, dehydrated in graded acetone series, and embedded in Araldite resin [37] . Ultrathin sections (50-75 nm) were cut using a diamond knife and contrasted with 2% uranyl acetate for 30 min [38] , followed by 2% lead citrate in sodium hydroxide solution for 10 min [39] . The samples were evaluated with a LEO-Zeiss 906 (Zeiss, Cambridge, UK) transmission electron microscope operated in 80 kV.
Statistical Analysis
All the statistical tests were performed with Statistica 6.0 software (StarSoft, Inc., Tulsa, OK). The quantitative results are expressed as mean 6 SE, and the analysis of variance and Tukey honest significance difference (HDS) tests were applied, with P 0.05 considered statistically significant.
RESULTS
Body Weight, Ovarian, and UPT Weights
During LET treatment, significant increases in the UPT (urethra þ prostatic tissue) and body weights were shown after 14 and 21 days of treatment, respectively. However, the ovaries presented mass increase since the third day of drug administration (Table 1) .
There were no significant alterations in body or ovarian weight in the TAM-treated groups. However, significant ANTIESTROGEN EFFECTS ON GERBIL FEMALE ORGANS changes in UPT weight were observed after 14 days of treatment.
Relative weights have been measured in order to represent the behavior of both the UPT and the ovaries in relation to total body weight ( Table 1) . As for the UPT, it is possible to observe that both treatments cause an increase in relative gland weight, although this growth had been higher during TAM therapy (LET þ46%, TAM þ80%). It can be noted that these drugs presented opposite effects in the ovaries. While LET caused a 36% gain in relative ovary weight, TAM provoked a 26% decrease in this weight.
PSA-Reactive Antigen Levels and Serum Steroid Hormone Levels
During LET therapy, a gradual increase was shown in serum testosterone levels, which reached 6.1 6 1.5 ng/ml after 21 days of treatment (Table 1) , a significant variation given the fact that this result is about four times higher than the serum levels found in untreated adult females. The LET treatment did not cause significant changes in the serum levels of estradiol and PSA-reactive antigen. However, a Pearson correlation test showed a considerable negative relation between the serum levels of testosterone and estradiol (r ¼ À0.62). The levels of human PSA-reactive antigen did not show a significant correlation with the serum levels of testosterone and estradiol.
TAM caused a significant decrease in serum testosterone levels on Days 3 and 7 of the treatment. During the first week of the treatment, the levels of this hormone reached only one-third (0.5 6 0.04 ng/ml) of the level observed in control females (1.6 6 0.5 ng/ml). But such a variation was transitory since the testosterone levels reached normal levels after 21 days of treatment (1.8 6 0.1 ng/ml). The levels of estradiol and PSAreactive antigen presented a nonsignificant oscillation throughout the TAM treatment. No significant correlation between the testosterone and estradiol levels or between testosterone and PSA-reactive antigen was observed. Nevertheless, a significant negative correlation coefficient was found between the levels of estradiol and PSA-reactive antigen (r ¼ À0.71).
Morphological and Immunocytochemical Characteristics of Prostates Treated with LET and TAM
Female prostate showed acini and ducts surrounding the urethra and inserted in the fibromuscular stroma. The epithelium comprises a single layer of polarized columnar secretory cells, together with basal cells (Fig. 1, a and b) . The surrounding stromal compartment includes fibroblasts and smooth muscle cells, in addition to fibrillar, neuronal, lymphatic, and vascular components (Fig. 1, c-e) .
Immunocytochemical assays presented AR-positive reaction in the nuclei of secretory epithelial cells and in fibroblasts adjacent to the epithelium (Fig. 1, f-h ). ERa-positive stain was observed in nuclei of the epithelial secretory cells (Fig. 1i ) and in nuclei and cytoplasm of cells in deeper areas of prostatic stroma (Fig. 1i) .
Ultrastructurally, the prostatic epithelial cells of normal adult females display an electron-dense cytoplasm, with several mitochondria, rough endoplasmic reticulum, and Golgi complex (Fig. 2a) . Numerous polymorphic secretory vesicles can be observed in the supranuclear region (Fig. 2b) . The nuclei of these cells are voluminous with decondensed chromatin (Fig. 2 , a and b). The stromal compartment is composed mainly of smooth muscle cells and fibroblasts (Fig. 2a) . The smooth muscle cells show few organelles, and they are surrounded by collagen fiber bundles (Fig. 2c) .
The morphological evaluations indicate that LET caused important alterations in the tissue arrangement of the gerbil female prostate, including evident glandular and secretory development. During the initial treatment phases (Days 3 and 7), the epithelial compartment became more developed, achieving a columnar pseudostratified pattern and forming several infoldings (Fig. 3, a-c) . Intraepithelial vesicles were observed in many acini. The epithelial cells became more voluminous and presented large supranuclear chromophobic areas and large nuclei (Fig. 3d) . The luminal compartment presented an apparent reduction (Fig. 3, a and c) . However, after 14 days of treatment, it was possible to observe an atrophy of the glandular epithelium and an expansion of the lumen (Fig. 3e) . The epithelial cells became smaller but with voluminous nuclei (Fig.  3f) . During the final phase of LET treatment (21 days), the epithelial compartment showed the same characteristics as observed during the first week of treatment (Fig. 3, g and h) .
TAM also caused changes in the glandular architecture of the gerbil female prostate. Throughout the treatment, there was gradual lumen enlargement, while the epithelial compartment decreased (Fig. 3, i-m) . The secretory epithelial cells became very small. Several apocrine secretory cells were observed, primarily on Treatment Day 14 (Fig. 3n) . In almost all the analyzed glands, the occurrence of intercellular spaces in the epithelial compartment was very common (Fig. 3, l and p) . After Day 14, it was possible to observe intraepithelial vesicles (Fig. 3, m and o) , which became a typical characteristic of the female prostate in the final phase of TAM treatment (Fig. 3o) .
The stromal compartment of the LET-treated prostate glands became denser, showing a larger amount of collagen fibers, especially after 7 days of treatment (Fig. 4a) . The reticular fibers located at the base of the epithelium became thicker and more sinuous (Fig. 4, b and c) . Large quantities of elastic system fibers were observed during all LET treatment phases (Fig. 4d) . TAM treatment presented a considerable increase of collagen fibers located near the epithelium (Fig. 4e) . The reticular fibers were more numerous and formed a layer at the base of the epithelium (Fig. 4, f and g ). TAM also caused the number of elastic system fibers to increase since these fibers were observed while forming complex networks near the ducts (Fig. 4h) . 
and TAM (i-p) for 3, 7, 14, and 21 days. Staining: H&E. On Days 3 and 7 of LET therapy (a-d), there was a formation of vesicles (arrows) and infoldings (arrowhead). On the 14th day (e and f), the luminal hypertrophy (*) promoted the distension of the epithelium (Ep). By the end of the therapy (g and h), a new epithelial growth was observed. Intraepithelial vesicles (arrows) were observed in all the phases of the treatment with TAM. Luminal hypertrophy and reduction of the secretory epithelium were detected after the seventh day of treatment (e-p). Observe the formation of intercellular spaces in the epithelium (arrowheads)
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The behavior of androgenic and estrogenic receptors in LET and TAM treatments can be observed in Figure 5 . LET caused greater AR expression in all treatment phases (Fig. 5, a and b) . On the other hand, LET-treated glands presented a smaller ESR1 stain since slight stains were observed only in the nuclei of epithelial cells and stromal cells near the epithelium (Fig.  5d) . During TAM treatment, the AR expression pattern was similar to the control one (Fig. 5e) . Under this treatment, the fibroblast nuclei and the secretory epithelial cells were AR positive (Fig. 5f) . However, the ESR1 stains were stronger and more numerous (Fig. 5g) , including in nuclei of secretory epithelial cells and the nuclei and cytoplasm of fibroblasts and cells located deeper within the prostatic stroma (Fig. 5h) .
Stereology
Within control female prostate, the epithelium, the lumen, and the nonmuscular stroma occupied equivalent volumes (26%-29%), and the muscular stroma represented about 18% of the glandular volume (Table 2 ). These results show that LET caused a significant increase in the proportion of the epithelial compartment in all the phases of the treatment, except Day 14 (14.1%), on which this tissue component was significantly diminished. The luminal compartment presented a significant oscillation in relative volume during the LET therapy, but it remained more developed on Treatment Days 14 and 21 (66.5% and 36.8 %, respectively). The relative frequency of muscular stroma was higher on treatment Days 3 (26%) and 7 (23.2%) but was significantly decreased on Days 14 (11%) and 21 (14%). The nonmuscular stroma presented significant drops in its volume density during all LET treatment phases.
In TAM-treated glands, it can be noted that the epithelial compartment gradually decreased its volume density after the seventh day of treatment, reaching 22.3% on Day 20 of drug administration. Inversely, the luminal compartment became more voluminous after the seventh day of TAM treatment, occupying 47.6% of the relative volume of the prostate gland. The muscular stroma became less frequent (14.5%) on   FIG. 4 . Distribution of stromal fibers in the female prostates treated with LET (a-d) and TAM (e-h) for 7, 14, and 21 days. Staining: Gö mö ris reticulin and Weigerts resorcinfucsin. In the LET treatment, the reticular fibers (arrows) were observed between the smooth muscle cells (smc) that surrounded the prostatic alveoli. The collagen (co) fibers were observed near the basal membrane and in deeper regions of the stroma. The elastic system (el) fibers became very developed on the base of the epithelium (Ep). During the TAM treatment, the reticular fibers experienced an intense development (arrows). Thick layers of co were observed right under the epithelium. Complex networks of elastic fibers were formed around the prostatic ducts (d). Bars ¼ 25 lm (a and e) and 10 lm (b-d and f-h).
Treatment Day 21, while the nonmuscular stroma decreased significantly after Day 14 (20% on Day 14 and 15.6% on Day 21). A Tukey parametric test showed that all the changes in density volume that occurred during the LET and TAM treatments were statistically significant (P 0.05).
Morphometry and Karyometry
Frequency analysis of epithelial cells showed that LET treatment caused a significant increase in the proportion of clear secretory cells (control ¼ 1.6 6 0.2%) that started to represent 3.8 6 0.2% in the prostatic epithelial population (Table 2) . On the other hand, there was a proportional reduction in the frequency of typical secretory cells, which dropped from 90.4 6 0.3% (control) to 88.4 6 0.3% on Treatment Day 21. The basal cells did not show significant changes in their proportion, amounting to an average of 7.7%-8.1% of the total number of epithelial cells. The TAM treatment did not significantly alter the frequency of the cell types analyzed.
The LET treatment also caused significant changes in the height of the secretory epithelial cells, which became taller during all the treatment phases (control ¼ 14. The TAM treatment induced a gradual decrease in thicknesses of secretory epithelium (control ¼ 14.4 6 0.3 lm; 21-day TAM ¼ 11 6 0.2 lm) and of smooth muscle cell layer (control ¼ 9.6 6 0.1 lm; 21-day TAM ¼ 7.2 6 0.1 lm). Inversely, the subepithelial layer of collagen fibers (control ¼ 2.4 6 0.05 lm) became successively thicker, reaching the maximum value of 3.8 6 0.1 lm on Treatment Day 21. These changes were statistically significant (P 0.05).
Analysis of the karyometric parameters indicated that LET treatment caused a gradual increase in the nucleus:cytoplasm ratio (control ¼ 0. 24 
Antiestrogens and Prostatic Dysplasia
In adult gerbil female prostate, both of the antiestrogenic therapies caused important dysplastic changes in the epitheli- um. Furthermore, in the stromal compartment was observed a characteristic desmoplasia, including a marked increase in the elastic system. The most common lesions observed during the LET treatment (21 days) include severe epithelial dysplasia (Fig. 6, a and b) , prostatitis (Fig. 6c) , stromal desmoplasia and epithelial hyperplasia (Fig. 6, a, b, and g ), and foci of inflammatory cells infiltrate associated to the epithelium (Fig.  6, c and d) . These abnormal tissue arrangements began to be detected after the first phase of the LET treatment, and they made up 100% of the analyzed glands at the end of the treatment.
At 14 and 21 days of TAM treatment, all the glands analyzed showed dysplastic growth (Fig. 7) , including hyperplasia and atypical epithelial cells population with mucinous cells concentration (Fig. 7, a-c and f) . The formation of microacini with neuroendocrine differentiation was observed in most of the analyzed glands (Fig. 7, d and e) . Another remarkable characteristic was the formation of extensive intercellular spaces in the secretory epithelium (Fig. 7g) . The stroma subjacent to the epithelial lesion regions showed a large amount of collagen fibers and elastic system fibers (Fig. 7, hj) . The muscle cells showed a thorny phenotype and a great quantity of organelles (Fig. 7i) . Figure 8 represents the histological ovary characteristics in control females (Fig. 8, a-c) and in those treated with LET (Fig.  8, d -f) and TAM (Fig. 8, g-h) . As no important histological differences between the phases of each treatment were observed, all data obtained for the experiments in question correspond to the same phase (21 days). During LET treatment (Fig. 8, d-f) , the granulosa cells showed intense proliferation and began to occupy the entire antral cavity. After 14 days of treatment, no follicle presented oocytes and many granulosa and stromal cells presented apoptosis (Fig. 8, e and f) .
Ovarian Structure
During TAM treatment (Fig. 8, g-i) , most of the follicles presented atresia. Nonatresic follicles presented an atypical proliferation of granulosa, whereas stromal cells showed intense hyperplasia.
DISCUSSION
The present work shows that the LET and TAM endocrine therapies cause important changes in the gerbil female prostate and ovaries. Although these two therapies have caused differentiated effects on the physiology and the maintenance of the gland's secretory activity, both induced dysplastic and 
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hyperplasic growth and atypical epithelial disorders in the female prostate.
During the LET treatment of gerbil females, the testosterone serum levels became gradually higher and reached values up to four times higher than those observed in untreated females. Experiments with aromatase-deficient male mice [40, 41] and with male rats submitted to inhibition of the same enzyme [22] yielded augmented serum testosterone levels and significantly diminished estradiol levels. These hormonal alterations occur because the deficiency or inhibition of aromatase prevents the peripheral conversion of testosterone into estrogen, which causes the accumulation of testosterone and the gradual decrease of E2 levels [42] [43] [44] .
In vivo studies showed that adult female rats treated daily with LET for 14 days presented an interruption of the ovarian cyclicity, an increase in testosterone levels, and a decrease in E2 serum levels to rates similar to those observed in ovariectomized animals [45] . A similar effect was also observed in women who used LET as endocrine therapy to treat breast cancer because it was possible to observe that this drug totally suppressed the E2 levels during the first 14 days of treatment [22] . Nevertheless, the results obtained with the gerbil females showed that 21-day LET treatment did not significantly alter E2 serum levels, although testosterone and estradiol levels were negatively correlated.
The rise in serum testosterone levels resultant from LET treatment induced glandular changes similar to those observed in adult gerbil females treated with testosterone [8] . These alterations include mainly epithelial and stromal hyperplasia, changes in hormonal receptor expression, increase in prostatic weight, and intensification of secretory activity.
The morphological and morphometric-stereological data showed that the epithelial compartment became more developed on Treatment Days 3 and 7, presenting, at these moments, hyperplastic behavior with formation of several infoldings and a great quantity of intraepithelial vesicles. Along with the luminal hypertrophy that occurred on the 14th day, the epithelium distended and the folds disappeared, although the occurrence of epithelial dysplasia had increased. These vesicles were also found in all phases of TAM treatment, and they are similar to the pseudocribriform pattern of intraepithelial neoplasia observed in testosterone-treated gerbil females [8] and males [46] .
On Treatment Day 21, a new hyperplastic growth was observed in the epithelium that consequently caused a volume reduction relative to the luminal and stromal compartments. This behavior pattern of the glandular components during the LET therapies shows that the glandular development occurred in alternating phases of epithelial proliferation and luminal hypertrophy, thus provoking intense prostatic growth.
The LET treatment also changed the proportion of epithelial cell types of the gerbil female prostate. The clear cells, which are rare in normal females, became twice as frequent, while the frequency of typical secretory cells decreased proportionally. Gerbil females under the effect of exogenous androgens presented up to five times more clear cells than untreated females. In these animals, the testosterone serum levels were up to six times higher than the levels observed in control females [8] . Under TAM treatment, in which the testosterone serum levels were not altered, no changes in the epithelial population frequency were observed. In addition, in our laboratory, Custodio and collaborators [11] , while studying the postnatal development of gerbil female prostate, showed that the clear cells are more frequent in senescence since they proliferate more in areas with neoplasic and dysplasic lesions. Thus, these results enable the conclusion that clear cell expression is altered by hormonal imbalance, especially by androgens.
The intense immunocytochemical reactions to AR we observed indicate that the increase of serum testosterone levels caused a greater expression of this receptor, a fact that can be associated with a greater prostatic development and with the increase of secretory activity that occurred during the LET treatment. On the other hand, it is possible to verify a decrease in number and intensity of ESR1 stains. Several works have shown that both the human and the rodent male prostates express the enzyme aromatase not only in normal conditions but also during the development of lesions [47] [48] [49] [50] [51] . Within the prostate, the blockage of this enzyme by LET causes the E2 tissue availability to decrease, hindering the binding of this hormone to its receptor [52] . Thus, the lesser ESR1 expression is likely due to the decrease of E2 intraprostatic levels.
The occurrence of dysplastic growth and high-grade epithelial atypia was very high during the 21 days of LET treatment. Similar changes were also found in adult gerbil 
682
females treated with testosterone, but under this treatment the lesions were less severe and less frequent [8] .
The results of the present work show that the increase in endogenous serum testosterone levels, caused by LET treatment, reproduces in detail the hyperandrogenic condition caused by the administration of androgens. However, LET presented a greater potential to develop lesions in the gerbil female prostate during the short-term experimental treatment. Aromatase inhibition affects the systemic hormonal balance by causing the testosterone serum levels to rise and the E2 serum levels to fall gradually [20, 53] . Although the serological analysis did not detect important alterations in E2 serum levels, it is believed that aromatase blockage diminished the tissue availability of this hormone. Studies with male mice deficient in aromatase expression show that the balance between androgens and estrogens is fundamental for the maintenance of normal prostate physiology [40, 51] . Thus, the hormonal imbalance caused by LET administration may have been the key event that triggered development of the prostatic lesions observed in the present experiment.
The morphological and morphometric-stereological analyses of the TAM-treated female prostates show that this drug provoked glandular hyperplasia and hypertrophy, which caused the relative prostate weight to increase up to 80%. The epithelial compartment started a regression process, while the lumen presented intense expansion. The ultrastructural analysis confirmed that the regression experienced by the epithelium was due to a decrease in the quantities of organelles and secretory vesicles, a fact directly related to reduction of the gland's secretory capacity.
The stromal compartment became denser, showing greater quantities of cells and elastic and collagen fibers. The collagen fibers underwent a remodeling process in order to accompany the expansion of the prostatic alveoli, while the elastic system fibers concentrated on the periductal region. The immunocytochemical analysis showed that TAM treatment did not affect AR expression in the female prostate. Nevertheless, the ERa stains were more frequent and more intense in the epithelial cells and in the deeper cells of the prostatic stroma. In TAM-treated females the serum E2 levels and the PSA-reactive antigen levels were not altered, but testosterone had dropped to less than half of baseline levels on Days 3 and 7 of the treatment.
TAM is a steroidal agent widely used to treat breast cancer because it acts as an estrogenic antagonist, preventing E2 from binding to ESR1 and ESR2 receptors [23] [24] [25] 54] . However, studies that evaluate the impact of TAM on the rodent reproductive tract showed that this drug performs a mixed agonist/antagonist function, depending on the type of organ being analyzed [29, 55, 56] . In the mouse male ventral prostate, TAM acts as an ESR1 partial agonist, triggering effects similar to those observed in estrogenized animals [57] .
The dysplastic growth and tissue modifications observed in female prostate glands treated with TAM are very similar to the alterations observed in the prostates of male rodents estrogenized during the intraembryonic or neonatal period [56, [58] [59] [60] . Furthermore, the initial decrease in serum testosterone levels is another factor that indicates the agonist activity of TAM in the gerbil female prostate since the estrogens interfere indirectly in androgen synthesis via action on the hypothalamus [40, 60] . On the other hand, the stromal hyperplasia and follicular atresia observed in the ovaries of these animals suggest that TAM acted as an estrogen antagonist on these organs. Thus, it is possible to conclude that TAM acted as an estrogen agonist on the gerbil female prostate, though it appears to have exercised antagonistic action on the ovarian physiology.
Hence, the antiestrogenic therapies with LET and TAM, which are widely used as primary means of treatment against the progression of ER-positive breast cancer [19, 20, 26, 61] , promote a series of complex effects that endanger the physiology of other hormone-dependent organs, such as the female prostate and the ovaries. The hormonal imbalance caused by the administration of these drugs causes profound changes in prostate morphology in a manner that is very similar to what occurs during the development of spontaneous lesions in postmenopausal women. Thus, these therapies must be used cautiously since long-term treatments can result in malignant lesions in the female prostate.
